Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L04AG02 L04AG02 Efalizumab
L04AG03 L04AG03 Natalizumab
L04AG04 L04AG04 Belimumab
L04AG05 L04AG05 Vedolizumab
L04AG06 L04AG06 Alemtuzumab
L04AG07 L04AG07 Begelomab
L04AG08 L04AG08 Ocrelizumab
L04AG09 L04AG09 Emapalumab
L04AG10 L04AG10 Inebilizumab
L04AG11 L04AG11 Anifrolumab
L04AG12 L04AG12 Ofatumumab
L04AG13 L04AG13 Teprotumab
L04AG14 L04AG14 Ublituximab
L04AG15 L04AG15 Divozilimab
L04AG17 L04AG17 Seniprutug
L04AG18 L04AG18 Sibeprenlimab
L04AG19 L04AG19 Axatilimab
L04AH L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
L04AH01 L04AH01 Sirolimus
L04AH02 L04AH02 Everolimus
L04AJ L04AJ Complement inhibitors
L04AJ01 L04AJ01 Eculizumab
L04AJ02 L04AJ02 Ravulizumab
L04AJ03 L04AJ03 Pegcetacoplan
L04AJ04 L04AJ04 Sutimlimab
L04AJ05 L04AJ05 Avacopan
L04AJ06 L04AJ06 Zilucoplan
L04AJ07 L04AJ07 Crovalimab
L04AJ08 L04AJ08 Iptacopan
L04AJ09 L04AJ09 Danicopan
Showing 30 of 7196 Records